Hyperlipidemia
Conditions
Interventions
viable probiotic group:Daily intake of viable probiotic
inactivated probiotic group:Daily intake of inactivated probiotic
control group:Daily intake of placebo
Sponsors
Cangzhou Integrated Traditional Chinese and Western Medicine Hospital
Eligibility
Sex/Gender
All
Age
40 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. People with high blood lipids (7.2>TC=5.2 mmol/L or 4.9>LDL=3.4 mmol/L or 5.6>TG=1.7 mmol/L). 2. Aged between 40 and 65 years old, regardless of gender. 3. Overweight or obese (34.9=BMI=24 kg/m2). 4. Give informed consent and volunteer to be tested. Sign written informed consent.
Exclusion criteria
Exclusion criteria: 1. Suffering from tumors, diabetes, infectious diseases, severe anemia, severe liver and kidney dysfunction, heart failure, stroke, autoimmune diseases, etc. 2. Pregnant and lactating women. 3. Those suffering from acute inflammation, infection or trauma. 4. Use of medications, antibiotics, antioxidants, vitamin supplements, or phytotherapeutic products that may interfere with the study intervention. 5. Intolerances and/or food allergies related to study products. 6. Those who have participated in clinical trials within the past 3 months or are currently participating in them. 7. The researcher believes that the subject is not suitable to participate in this trial for any reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lipid profiles;Body fat;Gut microbiota; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood glucose indicators;Blood pressure;inflammatory cytokines;liver function indicators;Weight management indicators;Biological information; | — |
Countries
China
Contacts
Public ContactWang Zhenqiang
Cangzhou Integrated Traditional Chinese and Western Medicine Hospital
Outcome results
None listed